文献速递白血病淋巴瘤

儿童血液恶性肿瘤合并毛霉病:一种可挽救的疾病——以色列儿童白血病研究组报告

Mucormycosis in children with haematological malignancies is a salvageable disease: a report from the Israeli Study Group of Childhood Leukemia.
PubMed 文献 · Br J Haematol · 2019-12-29

毛霉病与高危急性淋巴细胞白血病及年龄增长显著相关,38%患者死于毛霉病;接受一线治疗的患儿1年毛霉病相关死亡率为21±8%,5年总生存率为70±8%。

要点

  • 接受一线治疗的患儿1年毛霉病相关死亡率为21±8%,5年总生存率为70±8%。
  • 鼻脑型毛霉病与12周生存改善独立相关,复发恶性肿瘤与12周死亡增加相关。

核心结论

  • 儿童血液恶性肿瘤合并毛霉病并非不可救治,接受一线治疗的患儿常可挽救。

主要发现

  • 接受一线治疗的患者(n=24)1年毛霉病相关死亡率为21±8%,5年总生存率为70±8%。

临床怎么用

  • 对高危急性淋巴细胞白血病及年龄较大的儿童血液恶性肿瘤患者,应警惕毛霉病风险。
  • 鼻脑型毛霉病提示12周生存较好,复发恶性肿瘤提示预后较差。
  • 接受一线治疗的患儿毛霉病相关死亡率较低,积极治疗可挽救生命。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mucormycosis has emerged as an increasingly important cause of morbidity and mortality in immunocompromised patients, but contemporary data in children are lacking. We conducted a nationwide multicentre study to investigate the characteristics of mucormycosis in children with haematological malignancies. The cohort included 39 children with mucormycosis: 25 of 1136 children (incidence 2·2%) with acute leukaemias prospectively enrolled in a centralized clinical registry in 2004-2017, and an additional 14 children with haematological malignancies identified by retrospective search of the databases of seven paediatric haematology centres. Ninety-two percent of mucormycosis cases occurred in patients with acute leukaemias. Mucormycosis was significantly associated with high-risk acute lymphoblastic leukaemia (OR 3·75; 95% CI 1·51-9·37; P = 0·004) and with increasing age (OR 3·58; 95% CI 1·24-9·77; P = 0·01). Fifteen patients (38%) died of mucormycosis. Rhinocerebral pattern was independently associated with improved 12-week survival (OR 9·43; 95% CI 1·47-60·66; P = 0·02) and relapsed underlying malignancy was associated with increased 12-week mortality (OR 6·42; 95% CI, 1·01-40·94; P = 0·05). In patients receiving frontline therapy for their malignancy (n = 24), one-year cumulative mucormycosis-related mortality was 21 ± 8% and five-year overall survival was 70 ± 8%. This largest paediatric population-based study of mucormycosis demonstrates that children receiving frontline therapy for their haematological malignancy are often salvageable.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Elitzur S, Arad-Cohen N, Barg A, et al. Mucormycosis in children with haematological malignancies is a salvageable disease: a report from the Israeli Study Group of Childhood Leukemia. Br J Haematol. 2019. PMID: 31885080. doi:10.1111/bjh.16329

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。